Advertisement
Advertisement

Archive

2013: 109/4 (Apr) pp. 569-768

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

28 articles
1.
General mechanisms of coagulation and targets of anticoagulants (Section I)
Position Paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease

R. De Caterina (1), S. Husted (2), L. Wallentin (3), F. Andreotti (4), H. Arnesen (5), F. Bachmann (6), C. Baigent (7), K. Huber (8), J. Jespersen (9), S. D. Kristensen (10), G. Y. H. Lip (11), J. Morais (12), L. H. Rasmussen (13), A. Siegbahn (14), F. W. A. Verheugt (15), J. I. Weitz (16)

(1) Cardiovascular Division, Ospedale SS. Annunziata, G. d’Annunzio University, Chieti, Italy; (2) Medical-Cardiological Department, Aarhus Sygehus, Aarhus, Denmark; (3) Cardiology, Uppsala Clinical Research Centre and Department of Medical Sciences, Uppsala University, Uppsala, Sweden; (4) Institute of Cardiology, Catholic University, Rome, Italy; (5) MedicalDepartment, Oslo University Hospital, Ulleval, Norway; (6) Department of Medicine, University of Lausanne, Lausanne, Switzerland; (7) Cardiovascular Science, Oxford University,Oxford, UK; (8) 3rd Department of Medicine, Wilhelminenspital, Vienna, Austria; (9) Unit for Thrombosis Research, University of Southern Denmark, Esbjerg, Denmark; (10) Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark; (11) Haemostasis Thrombosis Vascular Biology Unit, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK; (12) Cardiology, Leiria Hospital, Leiria, Portugal; (13) Department of Cardiology, Thrombosis Center Aalborg, Aarhus University Hospital, Aalborg, Denmark; (14) Coagulation and Inflammation Science, Department of Medical Sciences, Uppsala University, Uppsala, Sweden; (15) Cardiology, Medical Centre, Radboud University Nijmegen, Nijmegen, Netherlands; (16) Thrombosis Atherosclerosis Research Institute, Hamilton General Hospital, Hamilton, Ontario, Canada

Thromb Haemost 2013 109 4: 569-579

https://doi.org/10.1160/TH12-10-0772

[Summary] [Free PDF] [Export citation]
2.

Editorial on Khadzhynov et al.

A. J. A. McLellan (1), M. P. Schlaich (1)

(1) The Alfred Hospital, Melbourne, Australia and Baker IDI Heart Diabetes Institute, Melbourne, Australia

Thromb Haemost 2013 109 4: 580-581

https://doi.org/10.1160/TH13-01-0064

[Summary] [Free PDF] [Export citation]
3.

Insight on Franks et al.

H. Herwald (1)

(1) Department of Clinical Sciences, Lund University Lund, Sweden

Thromb Haemost 2013 109 4: 582-582

https://doi.org/10.1160/TH13-02-0099

[Summary] [Free PDF] [Export citation]
4.

C. Hammerstingl (1), B. Pötzsch (2), G. Nickenig (1)

(1) Medizinische Klinik und Poliklinik II, Department of Cardiology, Angiology and Pneumology, University of Bonn, Bonn, Germany; (2) Institute for Experimental Haematology and Transfusion Medicine, University of Bonn, Bonn, Germany

Thromb Haemost 2013 109 4: 583-584

https://doi.org/10.1160/TH12-11-0821

[Summary] [Free PDF] [Export citation]
5.

H. Bounameaux (1), G. Agnelli (2)

(1) Division of Angiology and Haemostasis and Faculty of Medicine, University Hospitals of Geneva, Geneva, Switzerland; (2) Internal and Cardiovascular Medicine – Stroke Unit, University of Perugia, Perugia, Italy

Thromb Haemost 2013 109 4: 585-588

https://doi.org/10.1160/TH12-08-0627

[Summary] [Free PDF] [Export citation]
6.

F. Violi (1), L. Perri (1), L. Loffredo (1)

(1) Divisione I Clinica medica, Policlinico Umberto I, Sapienza University, Rome, Italy

Thromb Haemost 2013 109 4: 589-595

https://doi.org/10.1160/TH12-11-0860

[Summary] [Free PDF] [Export citation]
7.
Effective elimination of dabigatran by haemodialysis
A phase I single-centre study in patients with end-stage renal disease

See also Editorial by McLellan, Schlaich

D. Khadzhynov (1), F. Wagner (2), S. Formella (3), E. Wiegert (2), V. Moschetti (3), T. Slowinski (1), H.-H. Neumayer (1), K.-H. Liesenfeld (3), T. Lehr (3), S. Härtter (3), J. Friedman (4), H. Peters (1), A. Clemens (3)

(1) Department of Nephrology, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Humboldt University, Berlin, Germany; (2) Charité Research Organisation GmbH, Berlin,Germany; (3) Boehringer Ingelheim Pharma GmbH Co. KG, Ingelheim, Germany; (4) Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Conneticut, USA

Thromb Haemost 2013 109 4: 596-605

https://doi.org/10.1160/TH12-08-0573

[Summary] [PDF] [Pay per view] [Export citation]
8.

M. Raps (1), F. M. Helmerhorst (2), K. Fleischer (3), A. E. A. Dahm (4), F. R. Rosendaal (1), J. Rosing (5), P. Reitsma (6), P. M. Sandset (4), H. A. A. M. van Vliet (2, 7)

(1) Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; (2) Department of Reproductive Medicine, Leiden University Medical Center, Leiden, the Netherlands; (3) Department of Obstetrics and Gynaecology, University Medical Center St. Radboud, Nijmegen, the Netherlands; (4) Department of Haematology, Oslo University Hospital, and University of Oslo, Oslo, Norway; (5) Department of Biochemistry, Maastricht University, Maastricht, the Netherlands; (6) Department of Haemostasis and Thrombosis, Leiden University Medical Center, Leiden, the Netherlands; (7) Department of Gynaecology Catharina Hospital, Eindhoven, the Netherlands

Thromb Haemost 2013 109 4: 606-613

https://doi.org/10.1160/TH12-10-0771

[Summary] [PDF] [Pay per view] [Export citation]
9.

Online Supplementary Material

Q. Ding (1), L. Yang (2), S. M. Hassanian (2), A. R. Rezaie (2)

(1) Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; (2) Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Thromb Haemost 2013 109 4: 614-624

https://doi.org/10.1160/TH12-10-0760

[Summary] [PDF] [Pay per view] [Export citation]
10.

D. Landi (1), M. G. Beckman (2), N. R. Shah (1, 3), P. Bockenstedt (4), A. M. Grant (2), J. A. Heit (5), N. S. Key (6), R. Kulkarni (7), M. Manco-Johnson (8), S. Moll (6), C. S. Philipp (9), J. C. Andersen (10), T. L. Ortel (3)

(1) Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA; (2) Centers for Disease Control and Prevention, Atlanta, Georgia, USA; (3) Division ofHematology, Duke University Medical Center, Durham, North Carolina, USA; (4) Hematology Oncology, University of Michigan, Ann Arbor, Michigan, USA; (5) Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA; (6) University of North Carolina, Chapel Hill, North Carolina, USA; (7) Pediatrics Human Dev., Michigan State University, East Lansing, Michigan, USA; (8) University of Colorado and Children’sHospital, Aurora, Colorado, USA; (9) University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA; (10) Wayne State University, Karmanos Cancer Institute, Detroit, Michigan, USA

Thromb Haemost 2013 109 4: 625-632

https://doi.org/10.1160/TH12-08-0568

[Summary] [PDF] [Pay per view] [Export citation]
11.

M. N. Lauw (1, 2), B. Van der Holt (3), S. Middeldorp (2), J. C. M. Meijers (2), J. Cornelissen (4), B. J. Biemond (1)

(1) Department of Haematology, Academic Medical Center, Amsterdam, The Netherlands; (2) Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; (3) HOVON Data Centre, Erasmus MC-Daniel den Hoed, Rotterdam, The Netherlands; (4) Department of Haematology, Erasmus MC-Daniel den Hoed, Rotterdam, The Netherlands

Thromb Haemost 2013 109 4: 633-642

https://doi.org/10.1160/TH12-11-0845

[Summary] [PDF] [Pay per view] [Export citation]
12.

L. Xia (1), H. Zhou (1), L. Hu (1), H. Xie (1), T. Wang (1), Y. Xu (1), J. Liu (1), X. Zhang (1), J. Yan (2)

(1) Department of Clinical Laboratory and Hematology, School of Medical Science and Laboratory Medicine of Jiangsu University, Zhenjiang, Jiangsu, PR China; (2) Department of Cardiology, Affiliated Hospital, Jiangsu University, Zhenjiang, Jiangsu, PR China

Thromb Haemost 2013 109 4: 643-651

https://doi.org/10.1160/TH12-09-0655

[Summary] [PDF] [Pay per view] [Export citation]
13.

Online Supplementary Material

F. Ahmad (1, 2), U. Budde (3), R. Jan (1), F. Oyen (4), M. Kannan (1), R. Saxena (1), R. Schneppenheim (4)

(1) Department of Haematology, All India Institute of Medical Sciences (AIIMS), New Delhi, India; (2) Center for Translational Medicine, School of Medicine Temple University,Philadelphia, Pennsylvania, USA; (3) Medilys Laboratory, Coagulation, Asklepios Hospital Altona, Hamburg, Germany; (4) Department of Pediatric Haematology Oncology, University Medical Centre Hamburg Eppendorf, Hamburg, Germany

Thromb Haemost 2013 109 4: 652-660

https://doi.org/10.1160/TH12-10-0737

[Summary] [PDF] [Pay per view] [Export citation]
14.

Online Supplementary Material

H. Wada (1), M. Souri (2), R. Matsumoto (1), T. Sugihara (1), A. Ichinose (2)

(1) Department of Hematology, Kawasaki Medical School, Kurashiki, Japan; (2) Department of Molecular Patho-Biochemistry & -Biology, Yamagata University School of Medicine, Yamagata, Japan

Thromb Haemost 2013 109 4: 661-668

https://doi.org/10.1160/TH12-12-0936

[Summary] [PDF] [Pay per view] [Export citation]
15.

S. Ketha (1), P. Smithedajkul (2), A. Vella (3), R. Pruthi (4), W. Wysokinski (1), R. McBane (1, 4)

(1) Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA; (2) Division of Hospital Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA; (3) Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, USA; (4) Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA

Thromb Haemost 2013 109 4: 669-675

https://doi.org/10.1160/TH12-11-0865

[Summary] [PDF] [Pay per view] [Export citation]
16.

J. Haselboeck (1), A. Kaider (2), I. Pabinger (1), S. Panzer (3)

(1) Department of Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria; (2) Center for Medical Statistics, Informatics and Intelligent Systems, Section for Clinical Biometrics, Medical University of Vienna, Vienna, Austria; (3) Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria

Thromb Haemost 2013 109 4: 676-683

https://doi.org/10.1160/TH12-07-0522

[Summary] [PDF] [Pay per view] [Export citation]
17.

Online Supplementary Material

See also Insight by Herwald

Z. Franks (1), R. A. Campbell (1), A. Vieira de Abreu (1, 2), J. T. Holloway (1), J. E. Marvin (1, 3), B. F. Kraemer (1, 4), G. A. Zimmerman (1, 5), A. S. Weyrich (1, 3), M. T. Rondina (1, 6)

(1) Molecular Medicine Program, University of Utah School of Medicine, Salt Lake City, Utah, USA; (2) Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil; (3) University of Utah Health Sciences Center, Salt Lake City, Utah, USA; (4) Medizinische Klinik und Poliklinik I, Klinikum der Universitaet München, Germany; (5) Pulmonary and Critical Care Medicine, Department of Internal Medicine; (6) Divisions of General Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA

Thromb Haemost 2013 109 4: 684-695

https://doi.org/10.1160/TH12-08-0543

[Summary] [PDF] [Pay per view] [Export citation]
18.

S. Jesmin (1, 2, 3), S. Akter (1, 3), M. M. Rahman (4), M. M. Islam (1, 3), A. M. S. Islam (1, 3), S. N. Sultana (1, 3), C. N. Mowa (1), N. Yamaguchi (1), O. Okazaki (3), K. Satoru (2), S. Kimura (3), M. Hiroe (3), T. Mizutani (2), M. Moroi (3)

(1) Health Disease Research Center for Rural Peoples (HDRCRP), Mohammadpur, Dhaka, Bangladesh; (2) Graduate School of Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan; (3) National Center for Global Health and Medicine (NCGM), Shinjuku-ku, Tokyo, Japan; (4) Department of Global Health Policy, University of Tokyo, Tokyo, Japan

Thromb Haemost 2013 109 4: 696-705

https://doi.org/10.1160/TH12-09-0654

[Summary] [PDF] [Pay per view] [Export citation]
19.

N. Vuilleumier (1, 2), F. Montecucco (3, 4), G. Spinella (5), S. Pagano (1, 2), M. Bertolotto (4), B. Pane (5), A. Pende (4), K. Galan (3), P. Roux-Lombard (1, 6), C. Combescure (7), F. Dallegri (4), F. Mach (3), D. Palombo (5)

(1) Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland; (2) Department of Human Protein Science, Geneva Faculty of Medicine, Geneva, Switzerland; (3) Division of Cardiology Department of Internal Medicine, University of Geneva, Geneva, Switzerland; (4) First Medical Clinic, Laboratory of Phagocyte Physiopathology and Inflammation, Department of Internal Medicine, University of Genoa, Genoa, Italy; (5) Vascular and Endovascular Surgery Unit, Department of Surgery, San Martino Hospital, Genoa, Italy; (6) Division of Immunology and Allergy, Department of Internal Medicine, Geneva University Hospitals, Geneva, Switzerland; (7) CRC Division of clinical-epidemiology, Department of health and community medicine, University of Geneva University Hospitals of Geneva, Geneva, Switzerland

Thromb Haemost 2013 109 4: 706-715

https://doi.org/10.1160/TH12-10-0714

[Summary] [PDF] [Pay per view] [Export citation]
20.

M. Devetzi (1, 2), T. Trangas (2), A. Scorilas (3), D. Xynopoulos (4), M. Talieri (1)

(1) G. Papanicolaou Research Center of Oncology, Saint Savvas Cancer Hospital, Athens, Greece; (2) Department of Biological Applications Technologies, School of Sciences andTechnologies, University of Ioannina, Ioannina, Greece; (3) Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Athens, Athens, Greece; (4) Department of Gastroenterology, Saint Savvas Cancer Hospital, Athens, Greece

Thromb Haemost 2013 109 4: 716-725

https://doi.org/10.1160/TH12-07-0518

[Summary] [Free PDF] [Export citation]
  1-20 21-28